These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11515843)

  • 21. 6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity.
    Cuffari C; Théorêt Y; Latour S; Seidman G
    Gut; 1996 Sep; 39(3):401-6. PubMed ID: 8949645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Observations on the use of allopurinol in combination with azathioprine or mercaptopurine.
    Duley JA; Chocair PR; Florin TH
    Aliment Pharmacol Ther; 2005 Dec; 22(11-12):1161-2. PubMed ID: 16305731
    [No Abstract]   [Full Text] [Related]  

  • 23. [Progress of Research on 6-Thioguanine versus 6-Mercaptopurine in childhood ALL].
    Hou YJ; Zhao L; Liu XX; Ma YY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):622-6. PubMed ID: 27151041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 6-Thioguanine therapy in Crohn's disease--observational data in Swedish patients.
    Almer SH; Hjortswang H; Hindorf U
    Dig Liver Dis; 2009 Mar; 41(3):194-200. PubMed ID: 18799369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Results of therapy of active chronic hepatopathies with 6-mercaptopurine].
    Schneider G; Schimmelpfennig W; Theuer D; Wagner K; Zimmermann HB; Nack P
    Z Gesamte Inn Med; 1969 Apr; 24(8):Suppl:124-6. PubMed ID: 5802052
    [No Abstract]   [Full Text] [Related]  

  • 26. ECCO consensus: evidence-based use of 6-thioguanine therapy in Crohn's disease?
    de Boer NK; van Asseldonk DP; van Bodegraven A
    J Crohns Colitis; 2010 Oct; 4(4):484-5. PubMed ID: 21122549
    [No Abstract]   [Full Text] [Related]  

  • 27. Analytical Pitfalls of Therapeutic Drug Monitoring of Thiopurines in Patients With Inflammatory Bowel Disease.
    Simsek M; Meijer B; Mulder CJJ; van Bodegraven AA; de Boer NKH
    Ther Drug Monit; 2017 Dec; 39(6):584-588. PubMed ID: 29040228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Azathioprine or 6-mercaptopurine for inducing remission of Crohn's disease.
    Sandborn W; Sutherland L; Pearson D; May G; Modigliani R; Prantera C
    Cochrane Database Syst Rev; 2000; (2):CD000545. PubMed ID: 10796557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute sinusoidal obstruction syndrome after 6-thioguanine therapy for Crohn's disease.
    Kane S; Cohen SM; Hart J
    Inflamm Bowel Dis; 2004 Sep; 10(5):652-4. PubMed ID: 15472529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolving Considerations for Thiopurine Therapy for Inflammatory Bowel Diseases-A Clinical Practice Update: Commentary.
    Hanauer SB; Sandborn WJ; Lichtenstein GR
    Gastroenterology; 2019 Jan; 156(1):36-42. PubMed ID: 30195449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thioguanine-induced symptomatic thrombocytopenia.
    Wenzl HH; Högenauer C; Fickert P; Petritsch W
    Am J Gastroenterol; 2004 Jun; 99(6):1195. PubMed ID: 15180747
    [No Abstract]   [Full Text] [Related]  

  • 32. Formation of 6-thioguanine and 6-mercaptopurine from their 9-alkyl derivatives in mice.
    Nelson JA; Vidale E
    Cancer Res; 1986 Jan; 46(1):137-40. PubMed ID: 3940185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Initial clinical experience with allopurinol-thiopurine combination therapy in pediatric inflammatory bowel disease.
    Rahhal RM; Bishop WP
    Inflamm Bowel Dis; 2008 Dec; 14(12):1678-82. PubMed ID: 18521913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thioguanine-nucleotides do not predict efficacy of tioguanine in Crohn's disease.
    Herrlinger KR; Fellermann K; Fischer C; Kreisel W; Deibert P; Schoelmerich J; Fleig WE; Ruhl A; Reinshagen M; Greinwald R; Stange EF; Schwab M
    Aliment Pharmacol Ther; 2004 Jun; 19(12):1269-76. PubMed ID: 15191508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deoxythioguanosine and thioguanine.
    LePage GA; Gottlieb JA
    Clin Pharmacol Ther; 1973; 14(6):966-9. PubMed ID: 4749397
    [No Abstract]   [Full Text] [Related]  

  • 36. Safety and effectiveness of long-term allopurinol-thiopurine maintenance treatment in inflammatory bowel disease.
    Hoentjen F; Seinen ML; Hanauer SB; de Boer NK; Rubin DT; Bouma G; Harrell LE; van Bodegraven AA
    Inflamm Bowel Dis; 2013 Feb; 19(2):363-9. PubMed ID: 22605661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical usefulness of therapeutic drug monitoring of thiopurines in patients with inadequately controlled inflammatory bowel disease.
    Haines ML; Ajlouni Y; Irving PM; Sparrow MP; Rose R; Gearry RB; Gibson PR
    Inflamm Bowel Dis; 2011 Jun; 17(6):1301-7. PubMed ID: 20812329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thioguanine versus mercaptopurine in childhood ALL.
    Stanulla M; Schünemann HJ
    Lancet; 2006 Oct; 368(9544):1304-6. PubMed ID: 17046444
    [No Abstract]   [Full Text] [Related]  

  • 39. [Optimized thiopurine treatment in chronic inflammatory bowel disease].
    Kiszka-Kanowitz M; Theede K; Nielsen AM
    Ugeskr Laeger; 2014 May; 176(22):. PubMed ID: 25352005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thiopurines in Inflammatory Bowel Disease: New Findings and Perspectives.
    de Boer NKH; Peyrin-Biroulet L; Jharap B; Sanderson JD; Meijer B; Atreya I; Barclay ML; Colombel JF; Lopez A; Beaugerie L; Marinaki AM; van Bodegraven AA; Neurath MF
    J Crohns Colitis; 2018 Apr; 12(5):610-620. PubMed ID: 29293971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.